Design of a Kv1.3×CD25 bispecific antibody to preferentially inhibit activated T cells and ameliorate T-cell-driven colitis

European Journal of Pharmacology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles